Unlike other drug-related injuries, where the drugmaker can be held liable, when it comes to vaccine-related injuries, the government addresses complaints via a special program—which some say might unintentionally give legitimacy to misinformation that fuels the "'vaccine-hesitant' community."

Tiffany Swedeen nearly lost her job as a nurse after she was discovered stealing opioids from her hospital, but now, years after going through recovery, she is back at work—and hoping to serve as an example for other health care professionals dealing with substance use disorders.

American Health Line rounds up the latest health care news in the states.

Karli-Rae Kerrschneider faced a bill of almost $5,000 for nitrous oxide after recently giving birth—a bill that raised her ire because, as a nurse-midwife herself, Kerrschneider knew that the hospital where she works typically provides the same treatment for $100.

Fortune recently released its 65th annual ranked list of the 500 companies that generated the most revenue in the previous fiscal year, which included dozens of companies in the health care industry.

FDA on Friday approved the first gene therapy to treat a rare type of muscular atrophy in infants, and Novartis, which manufactures the drug, has said it will set the treatment's list price at $2.125 million—making it the highest-priced drug in the world.

Colorado Gov. Jared Polis (D) last week signed into law a bill that will cap out-of-pocket insulin costs for Colorado residents with diabetes at $100 per month.

Senate Health, Education, Labor, and Pensions Committee Chair Lamar Alexander (R-Tenn.) and Sen. Patty Murray (D-Wash.), the committee's ranking member, on Thursday unveiled bipartisan draft legislation that aims to address so-called "surprise" medical bills and lower prescription drug costs in the United States.

American Health Line rounds up the latest health care news in the states.

President Trump during a closed-door meeting on Wednesday told Democratic congressional leaders he would not work with them on key issues unless they halt investigations into his presidency—comments some observers say could threaten bipartisan efforts to address high prescription drug prices in the United States.